Christine actively works to secure protection for the intellectual property of her clients through the preparation and prosecution of U.S. and international patent applications. 


She leverages her advanced degree and post-doctoral work in biomedical sciences to provide a unique perspective on complex issues in the life sciences and pharmaceutical industries.

Christine has worked on technologies across the medical, pharmaceutical, biotechnology, agricultural, and chemical sectors. Her patent prosecution work has involved technologies directed to biologics, biosimilars, antibodies, gene therapies, CRISPR-Cas gene editing, RNA interference, PCR technology, nucleic acids, proteins, bioactive peptides for use in pharmaceutical and agricultural applications, medicinal chemistry, antibiotics, radiopharmaceuticals, medical and research diagnostic assays, biomarkers, and agrochemicals. Other subject areas include oil and gas chemistry, surfactants, and flame retardants and suppressants. 

She has experience working with a range of clients including individual inventors, university tech transfer offices, small startups and large biotechnology companies. Christine also assists clients with patentability, freedom-to-operate opinions, due diligence projects and prior art searches.


Christine's graduate and post-doctoral work focused on neuroactive drug-receptor interactions and modulation and the role of dopamine on light adaptation. This research gives her a unique ability to analyze complex issues in the life sciences and pharmaceutical industries.

For two years, Christine served as a consultant and project manager with the BALSA group, performing technology assessments and market analyses for clients in the St. Louis biotechnology sector.

She has authored four publications on the activity and pharmacological modulation of NMDA receptors and an author of a reference chapter on neuronal electrophysiology.

News & Insights


"A Clickable Analogue of Ketamine Retains NMDA Receptor Activity, Psychoactivity and Accumulates in Neurons," Science Reports, 2016

"Interaction Between Positive Allosteric Modulators and Trapping Blockers of the NMDA Receptor Channel," British Journal of Pharmacology, 2015

"Electrophysiology of Neurons," Neural Stem Cell Assays, First Edition, 2014

"Indistinguishable Synaptic Pharmacodynamics of the N-methyl-D-aspartate Receptor Channel Blockers Memantine and Ketamine," Molecular Pharmacology, 2013

"Synaptic NMDA Receptors Mediate Hypoxic Excitotoxic Death," Journal of Neuroscience, 2012

Professional & Civic Activities

Professional & Civic Activities

Bar Association of Metropolitan St. Louis

American Bar Association

American Intellectual Property Association

Intellectual Property Organization


  • U.S. Patent and Trademark Office, 2017


Washington University, Ph.D., Neuroscience, 2014

Mount Saint Mary's University, B.S., summa cum laude, 2009

Jump to Page

We use cookies on our website to improve functionality and performance, analyze website traffic and enable social media features. By continuing to use our website, you agree to our use of cookies. For more information, please see our Cookie Policy.